Clinical Research Directory

10 Year Registry of Children (Ages 2-17 Years) With Eczema That Have Used Pimecrolimus

Sponsor: Bausch Health Americas, Inc.

Summary

This study will examine the risk of systemic malignancies in pediatric patients with atopic dermatitis exposed to Elidel 1% cream.

Official title: A Prospective 10 Year Observational Registry of Pediatric Subjects (Age Greater Than or Equal to Two Years to Age Less Than or Equal to 17 Years) With Atopic Dermatitis Who Have Used Elidel Cream 1% (Pimecrolimus)

Key Details

Conditions

Interventions

Locations (1)